Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chondrosarcoma, Mesenchymal × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 32 Ovarian Neoplasms 12 Leiomyosarcoma 12 Liposarcoma 10 Neoplasms 7 Sarcoma, Ewing 4 Neoplasm Metastasis 4 Liposarcoma, Myxoid 4 Sarcoma, Synovial 3 Rhabdomyosarcoma 3 Histiocytoma, Malignant Fibrous 3 Breast Neoplasms 3 Solitary Fibrous Tumors 2 Sarcoma, Alveolar Soft Part 2 Prostatic Neoplasms 2 Osteosarcoma 2 Neurofibrosarcoma 2 Neoplasms by Site 2 Mesothelioma, Malignant 2 Malignant mesenchymal tumor 2 Ichthyosis, X-Linked 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2 Fibrosarcoma 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Bone Neoplasms 2 Wilms Tumor 1 Uterine Neoplasms 1 Unspecified Childhood Solid Tumor, Protocol Specific 1

Interventions

regorafenib 1 pazopanib 1 Trabectedin 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Pharmacogenomic Testing 1 Ifosfamide 1 HhAntag691 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305548 2026-03-27

ISG-MCS

Italian Sarcoma Group

Phase 2 Recruiting

Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡